RedHill Biopharma reported $12.56M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Cara Therapeutics USD 38.44M 4.69M Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
Cronos Group USD 944.09M 21.94M Dec/2025
RedHill Biopharma USD 12.56M 644K Jun/2025